egr-1 and protein phosphatase 2A would be predicted to favor vascular smooth muscle regression promoting coronary vasodilatation and having the effect of augmenting oxygen delivery to hypertrophic, hypoxically perfused myocardium. Although not literature-validated as cardiac ‘targets’, increased neonatal ...